XM does not provide services to residents of the United States of America.

Australia shares end lower; eyes on key data points this week



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Australia shares end lower; eyes on key data points this week</title></head><body>

ASX 200 logs worst session in 2 weeks

Inflation prints from U.S. and China this week

Healthcare stocks snap 3-day winning streak

By Sneha Kumar

July 8 (Reuters) -Australian shares fell on Monday, dragged by losses in heavyweight miners as commodity prices declined on demand concerns from top consumer China, while investors exercised caution ahead of critical data this week.

The S&P/ASX 200 benchmark index .AXJO closed 0.8% lower at 7,763.2 points at the end of its worst session in two weeks. The benchmark rose 0.7% last week.

"Markets leaned in a risk-averse direction to kick off the new week ahead of some key upcoming events," said Tim Waterer, chief market analyst at KCM Trade.

"The heavy economic calendar this week kept risk appetite in check today."

On Thursday, the U.S. inflation reading is expected to offer further clues on the Federal Reserve's future policy decisions after June unemployment rate touched a 2-1/2-year high, boosting rate cut hopes.

Meanwhile, Australian equities will be sensitive to how the Chinese inflation data plays out on Wednesday, with an eye on any signs of price pressures starting to appear in the world's second largest economy, KCM Trade's Waterer said.

Mining stocks .AXMM lost 1.8% with giants BHP Group BHP.AX, Rio Tinto RIO.AX and Fortescue FMG.AX declining between 2% and 2.6%.

Healthcare stocks .AXHJ snapped a three-day winning streak to end 1% lower.

Top pharmaceutical firm CSL CSL.AX recorded its worst session in more than seven weeks and lost 1.5%.

Rate-sensitive financials .AXFJ retreated 0.3% with three of the "Big Four" banks losing between 0.04% and 0.5%.

Energy stocks .AXEJ shed 1.5% during their worst session in two weeks. Crude prices declined on easing of Middle East tensions and a potential supply disruption from the U.S. O/R

Across the Tasman Sea, New Zealand's benchmark S&P/NZX 50 index .NZ50 fell 0.4% to 11,745.53 points.

The country's central bank is expected to keep the cash rate unchanged at 5.50% on Wednesday. Interest rate futures price in around 40 basis points of rate cuts this year. 0#RBNZWATCH




Reporting by Sneha Kumar in Bengaluru; Editing by Mrigank Dhaniwala

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.